Number of the records: 1
Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy
SYS 0029046 LBL 00000naa^^22^^^^^^^^450 005 20090702090841.9 100 $a 20090615a2009 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy $f Z. Kleibl ... [et al.] 215 $c ilustr. (aj fareb.), grafy, obr., tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0028544 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 56, no. 4 (2009), s. 303-316 $1 210 $a Bratislava $c AEPress $d 2009 $1 215 $a s. 279-370 541 1-
$a Vplyv variantov kódujúcich sekvencie génu dihydropyrimidín dehydrogenázy (DPYD) na vývoj toxicity spojenej s fluoropyrimidínom u pacientov s vysokým stupňom toxicity a u pacientov s výbornou toleranciou chemoterapie fluoropyrimidínom $z slo 606 1-
$3 sllk_un_auth*d005472 $a fluorouracil $x analógy a deriváty $x toxicita $x účinky nežiaduce $2 mesh 606 1-
$3 sllk_un_auth*d011743 $a pyrimidíny $2 mesh 606 1-
$3 sllk_un_auth*d005796 $a gény $x účinky liekov $2 mesh 606 2-
$3 sllk_un_auth*d004252 $a analýza DNA, mutačná $2 mesh 606 2-
$3 sllk_un_auth*d006239 $a haplotypy $2 mesh 606 2-
$3 sllk_un_auth*d004358 $a farmakoterapia $x účinky nežiaduce $2 mesh 606 2-
$3 sllk_un_auth*d055106 $a štúdia celogenómová asociačná $2 mesh 610 2-
$a fluoropyrimidíny 610 2-
$a 5-fluorouracil 610 2-
$a gén dihydropyrimidín dehydrogenázy 610 2-
$a varianty génu 701 -1
$3 sllk_un_auth*p0061136 $a Kleibl $b Zdeněk $p Ústav biochemie a experimentální onkologie 1. LF UK, Praha $4 070 701 -1
$3 sllk_un_auth*0010290 $a Fidlerová $b J. $p Ústav biochemie a experimentální onkologie 1. LF UK, Praha $4 070 701 -1
$3 sllk_un_auth*0001856 $a Kleiblová $b Petra $p Institute of Biochemistry and Experimental Oncology $4 070 701 -1
$3 sllk_un_auth*0008134 $a Kormunda $b Stanislav $p Institute of Social Medicine, Medical Faculty of Charles University, Pilsen $4 070 701 -1
$3 sllk_un_auth*0010291 $a Bílek $b M. $p Institute of Forensic Medicine and Toxicology, Charles University in Prague, 1st Faculty of Medicine and General Teaching Hospital, Prague $4 070 701 -1
$3 sllk_un_auth*0010292 $a Boušková $b K. $p Ústav biochemie a experimentální onkologie 1. LF UK, Praha $4 070 701 -1
$3 sllk_un_auth*0001855 $a Ševčík $b Jan $p Institute of Biochemistry and Experimental Oncology, Prague $4 070 701 -1
$3 sllk_un_auth*p0027803 $a Novotný $b Jan $p Onkologická klinika 1. LF UK a VFN, Praha $4 070 801 -0
$a SK $b BA006 $c 20090615 $g AACR2
Number of the records: 1